BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 17410413)

  • 1. Immunohistochemical properties of silent corticotroph adenoma and Cushing's disease.
    Iino K; Oki Y; Matsushita F; Yamashita M; Hayashi C; Miura K; Nishizawa S; Nakamura H
    Pituitary; 2007; 10(1):35-45. PubMed ID: 17410413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1/3.
    Righi A; Faustini-Fustini M; Morandi L; Monti V; Asioli S; Mazzatenta D; Bacci A; Foschini MP
    Endocrine; 2017 May; 56(2):286-297. PubMed ID: 27491554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, hormonal and molecular characterization of pituitary ACTH adenomas without (silent corticotroph adenomas) and with Cushing's disease.
    Raverot G; Wierinckx A; Jouanneau E; Auger C; Borson-Chazot F; Lachuer J; Pugeat M; Trouillas J
    Eur J Endocrinol; 2010 Jul; 163(1):35-43. PubMed ID: 20385723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential gene expression in ACTH -secreting and non-functioning pituitary tumors.
    Tateno T; Izumiyama H; Doi M; Yoshimoto T; Shichiri M; Inoshita N; Oyama K; Yamada S; Hirata Y
    Eur J Endocrinol; 2007 Dec; 157(6):717-24. PubMed ID: 18057378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma.
    Tateno T; Izumiyama H; Doi M; Akashi T; Ohno K; Hirata Y
    Endocr J; 2007 Dec; 54(5):777-82. PubMed ID: 17917309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of somatostatin and dopamine receptor subtype genes in adrenocorticotropin (ACTH)-secreting pituitary tumors and silent corticotroph adenomas.
    Tateno T; Kato M; Tani Y; Oyama K; Yamada S; Hirata Y
    Endocr J; 2009; 56(4):579-84. PubMed ID: 19318729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ACTH secretion in Cushing's adenoma and clinically silent corticotroph adenoma by cell immunoblot assay.
    Kojima Y; Suzuki S; Yamamura K; Ohhashi G; Yamamoto I
    Endocr J; 2002 Jun; 49(3):285-92. PubMed ID: 12201210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of absent prohormone convertase 1/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I--immunohistochemical study.
    Ohta S; Nishizawa S; Oki Y; Yokoyama T; Namba H
    Pituitary; 2002; 5(4):221-3. PubMed ID: 14558669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications after transsphenoidal surgery for patients with Cushing's disease and silent corticotroph adenomas.
    Smith TR; Hulou MM; Huang KT; Nery B; de Moura SM; Cote DJ; Laws ER
    Neurosurg Focus; 2015 Feb; 38(2):E12. PubMed ID: 25639314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why don't corticotroph tumors always produce Cushing's disease?
    García-Martínez A; Cano DA; Flores-Martínez A; Gil J; Puig-Domingo M; Webb SM; Soto-Moreno A; Picó A
    Eur J Endocrinol; 2019 Sep; 181(3):351-361. PubMed ID: 31319379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease.
    Teshima T; Hara Y; Takekoshi S; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2009 Jan; 36(1):3-12. PubMed ID: 18818046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of prohormone convertases 1/3 and 2 in the human pituitary gland and pituitary adenomas: analysis by immunohistochemistry, immunoelectron microscopy, and laser scanning microscopy.
    Takumi I; Steiner DF; Sanno N; Teramoto A; Osamura RY
    Mod Pathol; 1998 Mar; 11(3):232-8. PubMed ID: 9521468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nur77 gene expression levels were involved in different ACTH-secretion autonomy between Cushing's disease and subclinical Cushing's disease.
    Tabuchi Y; Kitamura T; Fukuhara A; Mukai K; Onodera T; Miyata Y; Hamasaki T; Oshino S; Saitoh Y; Morii E; Otsuki M; Shimomura I
    Endocr J; 2016 Jun; 63(6):545-54. PubMed ID: 27025408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumours--an in vitro and immunohistochemical study.
    Desai B; Burrin JM; Nott CA; Geddes JF; Lamb EJ; Aylwin SJ; Wood DF; Thakkar C; Monson JP
    Eur J Endocrinol; 1995 Jul; 133(1):25-32. PubMed ID: 7542980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evaluation of the post-translational processing of chromogranin A in human pituitary adenomas.
    Heaney AP; Curry WJ; Pogue KM; Armstrong VL; Mirakhur M; Sheridan B; Johnston CF; Buchanan KD; Atkinson AB
    Pituitary; 2000 Oct; 3(2):67-75. PubMed ID: 11141698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACTH response to desmopressin in a patient with acromegaly; expression of corticotropin-releasing factor, urocortins and vasopressin V1b receptor in GH-producing pituitary adenoma.
    Arihara Z; Sakurai K; Osaki Y; Fukazawa H; Yamada S; Inoshita N; Murakami O; Ohba K; Takahashi K
    Endocr J; 2011; 58(12):1029-36. PubMed ID: 21908929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Parameters to Distinguish Silent Corticotroph Adenomas from Other Nonfunctioning Pituitary Adenomas.
    Kim D; Ku CR; Park SH; Moon JH; Kim EH; Kim SH; Lee EJ
    World Neurosurg; 2018 Jul; 115():e464-e471. PubMed ID: 29678704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
    Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
    J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.
    Testa RM; Albiger N; Occhi G; Sanguin F; Scanarini M; Berlucchi S; Gardiman MP; Carollo C; Mantero F; Scaroni C
    Eur J Endocrinol; 2007 Feb; 156(2):241-8. PubMed ID: 17287414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenomas. An immunohistochemical study of hormone production and chromogranin localization.
    DeStephano DB; Lloyd RV; Pike AM; Wilson BS
    Am J Pathol; 1984 Sep; 116(3):464-72. PubMed ID: 6089568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.